AI-enabled ECG system significantly reduces hospital mortality rates by identifying at-risk patients

As­traZeneca’s add-on pill for the rare blood dis­or­der parox­ys­mal noc­tur­nal he­mo­glo­bin­uria (PNH) won its first ap­proval in Japan, the com­pa­ny an­nounced Fri­day. The drug, an

The FDA is set­ting out to stream­line in­ter­na­tion­al reg­u­la­tions of gene ther­a­pies with a pi­lot pro­gram to re­view ap­pli­ca­tions along­side glob­al reg­u­la­to­ry part­ners, an agency